NEWS
- ADC Advances in 2026: New Approvals and Emerging Breakthroughs
- Published with Our PEG Products? Get 20% OFF Your Next Order
- ADCs in Autoimmune Diseases: Expanding ADC Technology Beyond Oncology
- Nectin-4 ADCs at ASCO 2026: Pipeline and Clinical Updates
- The Applications and Challenges of Lipid Nanoparticles
- PROTAC Vepdegestrant Approved: PROTAC Linker Design & PEG Linkers
- FDA Approved PEGylated Drugs By 2026
- Click Chemistry Applied To Antiboday Drug Conjugates In Clinical Development
- Beyond GLP-1 - Novel Targets for Weight Loss
- Global Sales of Antibody-drug Conjugates (ADCs) in 2025
